Tag Archives: Shahram Seyedin-Noor

East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More

What summer doldrums? It’s still not even Labor Day, yet the deals are already coming fast and furious. So fire up the grill and read on for some Series A rounds, crossover investments, data readouts, option-to-buy deals and more. —As Xconomy reported this week, a stealthy Cambridge, MA-based startup called X4 Pharmaceuticals raised a $37.5 […]

Posted in Boston, Boston blog main, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More

In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer

If you tried to count on one hand the number of New York City biotech startups to get a substantial funding round this year, you’d probably have a few fingers left over. A stealthy startup out of Rockefeller University named Rgenix is one of the lucky few to score a significant haul, and today it’s […]

Posted in Boston blog main, National blog main, National top stories, New York, New York blog main, New York top stories, San Diego blog main, San Diego top stories, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer